首页> 外文期刊>Medicine. >Prognostic value of serum proadrenomedullin in catheter-related bloodstream infection in the intensive care unit: A prospective observational study
【24h】

Prognostic value of serum proadrenomedullin in catheter-related bloodstream infection in the intensive care unit: A prospective observational study

机译:血清前肾上腺髓质素对重症监护病房导管相关性血流感染的预后价值:一项前瞻性观察研究

获取原文
           

摘要

Patients with catheter-related bloodstream infection (CRBSI) have a poor prognosis. Proadrenomedullin (pro-ADM) has emerged as a valuable marker of sepsis. The potential role of pro-ADM in predicting the prognosis of CRBSI was evaluated. We enrolled 25 CRBSI patients and pro-ADM level was measured within 24 hours after each admission. Survival was assessed after 28 days. Among 25 patients with CRBSI, 14 patients survived. Pro-ADM in survivors was significantly lower than that in non-survivors (3.71 ± 1.30 vs 5.58 ± 1.18 nmol/L). The area under the curve (AUC) for pro-ADM was 0.87 (95% CI 0.68–0.97) with a cut-off value of 4.67 nmol/L, providing sensitivity of 85.7% and specificity of 81.8%. The AUCs for PCT, WBC, and CRP were 0.76 (95% CI 0.55–0.90), 0.72 (95% CI 0.50–0.88), and 0.69 (95% CI 0.48–0.86), respectively. Kaplan–Meier survival curves showed pro-ADM ≥ 4.67 nmol/L was associated with higher mortality (log-rank p = 0.001). Moreover, the pro-ADM level was significantly higher in patients with septic shock than those without shock (5.44 ± 1.17 vs 3.54 ± 1.18nmol/L). The mortality of patients with septic shock was higher than that of patients without shock (69.2% vs 16.7%, P = .008). In conclusion, pro-ADM could be used as a prognostic marker of CRBSI in critically ill patients.
机译:患有导管相关性血流感染(CRBSI)的患者预后较差。前肾上腺髓质素(pro-ADM)已成为败血症的重要标志。评价了pro-ADM在预测CRBSI预后中的潜在作用。我们招募了25名CRBSI患者,并在每次入院后24小时内测量了pro-ADM水平。 28天后评估存活率。在25例CRBSI患者中,有14例幸存。存活者中的Pro-ADM显着低于非存活者(3.71±1.30 vs 5.58±1.18 nmol / L)。前ADM的曲线下面积(AUC)为0.87(95%CI 0.68-0.97),截断值为4.67 nmol / L,灵敏度为85.7%,特异性为81.8%。 PCT,WBC和CRP的AUC分别为0.76(95%CI 0.55-0.90),0.72(95%CI 0.50-0.88)和0.69(95%CI 0.48-0.86)。 Kaplan–Meier生存曲线显示pro-ADM≥4.67 nmol / L与更高的死亡率相关(对数秩p = 0.001)。此外,败血性休克患者的pro-ADM水平显着高于无休克的患者(5.44±1.17 vs 3.54±1.18nmol / L)。败血性休克患者的死亡率高于无休克患者(69.2%比16.7%,P = .008)。总之,pro-ADM可用作危重患者CRBSI的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号